Transcatheter Mitral Valve Repair Using a Novel Device for a High-Surgical-Risk Patient With DMR

Jiaqi Dai; Shouzheng Wang; Kairui Yang; Mier Ma; Da Zhu; Xiangbin Pan

doi:10.1016/j.jaccas.2024.102334

Transcatheter Mitral Valve Repair Using a Novel Device for a High-Surgical-Risk Patient With DMR

JACC Case Rep. 2024 Apr 6;29(10):102334. doi: 10.1016/j.jaccas.2024.102334. eCollection 2024 May 15.

Authors

Jiaqi Dai¹, Shouzheng Wang², Kairui Yang¹, Mier Ma¹, Da Zhu¹, Xiangbin Pan^{1

2}

Affiliations

¹ Department of Structure Heart Center, Fuwai Yunnan Hospital, Chinese Academy of Medical Sciences, Affiliated Cardiovascular Hospital of Kunming Medical University, Kunming, China.
² Department of Structural Heart Disease, National Center for Cardiovascular Disease, China & Fuwai Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.

Abstract

Transcatheter edge-to-edge repair (TEER) has been established as a safe and effective option for treating patients with severe symptomatic degenerative mitral regurgitation (MR) who are at prohibitive surgical risk. However, the significant cost presents a considerable disease burden in low-income countries. This case details the treatment of a high-surgical-risk patient with severe degenerative MR by using the GeminiOne (Peijia Medical) system-a novel Chinese TEER device.

Keywords: China medical devices; mitral regurgitation; transcatheter mitral valve edge-to-edge repair.

Publication types

Case Reports